148 related articles for article (PubMed ID: 30548467)
1. Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
Saini NY; Patel RD; Varma A; Bashir Q; Delgado R; Rondon G; Popat U; Hosing C; Nieto Y; Kebriaei P; Weber DM; Thomas SK; Lee HC; Manasanch EE; Orlowski RZ; Champlin RE; Qazilbash MH; Patel KK
Am J Hematol; 2019 Mar; 94(3):E72-E74. PubMed ID: 30548467
[No Abstract] [Full Text] [Related]
2. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Ordway S; Gilbert L; Wanko S
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
[TBL] [Abstract][Full Text] [Related]
3. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Cook G; Iacobelli S; van Biezen A; Ziagkos D; LeBlond V; Abraham J; McQuaker G; Schoenland S; Rambaldi A; Halaburda K; Rovira M; Sica S; Byrne J; Sanz RG; Nagler A; van de Donk NW; Sinisalo M; Cook M; Kröger N; De Witte T; Morris C; Garderet L
Haematologica; 2017 Jan; 102(1):160-167. PubMed ID: 27634201
[TBL] [Abstract][Full Text] [Related]
4. [Autologous peripheral blood stem cell transplantation for POEMS syndrome].
Liao LS; Zheng ZH; Qu S; Wei TN; Xie Y; Lin Y; Chen BY; Chen WM
Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):209-212. PubMed ID: 30803180
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study.
Drach J; Huang H; Samoilova O; Belch A; Farber C; Bosly A; Novak J; Zaucha J; Dascalescu A; Bunworasate U; Masliak Z; Vilchevskaya K; Robak T; Pei L; Rooney B; van de Velde H; Cavalli F
Leuk Lymphoma; 2018 Apr; 59(4):896-903. PubMed ID: 29338540
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
[No Abstract] [Full Text] [Related]
7. Autologous peripheral stem cell transplant for POEMS syndrome: a case report.
Gupta S; Rana V; Chandra D; Giralt SA; Juneja HS
Hematology; 2006 Oct; 11(5):361-3. PubMed ID: 17607587
[TBL] [Abstract][Full Text] [Related]
8. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
Zhao H; Huang XF; Gao XM; Cai H; Zhang L; Feng J; Cao XX; Zhou DB; Li J
Leukemia; 2019 Apr; 33(4):1023-1029. PubMed ID: 30700844
[TBL] [Abstract][Full Text] [Related]
9. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
Ganti AK; Pipinos I; Culcea E; Armitage JO; Tarantolo S
Am J Hematol; 2005 Jul; 79(3):206-10. PubMed ID: 15981232
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and prognostic analysis of frontline Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone regimens (VR-CAP) for patients with mantle cell lymphoma].
Cao YW; Zheng Z; Xu PP; Cheng S; Wang L; Qian Y; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):415-419. PubMed ID: 34218585
[No Abstract] [Full Text] [Related]
11. Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome.
Yasunaga M; Yasuda Y; Honda A; Maki H; Toyama K; Masamoto Y; Bujo C; Amiya E; Hatano M; Ono M; Komuro I; Kurokawa M
Ann Hematol; 2021 Apr; 100(4):1097-1100. PubMed ID: 32766933
[No Abstract] [Full Text] [Related]
12. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
Murayama T; Fukuda T; Okumura H; Sunami K; Sawazaki A; Maeda Y; Tsurumi H; Uike N; Hidaka T; Takatsuka Y; Eto T; Tsuda H; Fujisaki T; Miyamoto T; Tsuneyoshi N; Iyama S; Nagafuji K; Harada M
Int J Hematol; 2016 Jun; 103(6):676-85. PubMed ID: 27084252
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.
Ohwada C; Sakaida E; Kawajiri-Manako C; Nagao Y; Oshima-Hasegawa N; Togasaki E; Muto T; Tsukamoto S; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Shimizu N; Misawa S; Iseki T; Kuwabara S; Nakaseko C
Blood; 2018 May; 131(19):2173-2176. PubMed ID: 29599110
[No Abstract] [Full Text] [Related]
14. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
15. Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.
Tam CS; Khouri IF
Leuk Lymphoma; 2009 Aug; 50(8):1239-48. PubMed ID: 19562639
[TBL] [Abstract][Full Text] [Related]
16. [Papillary edema and the POEMS syndrome].
Gatinel D; Larroche C; Fanjkuchen F; Chaine G; Guillevin L
J Fr Ophtalmol; 1998 Feb; 21(2):133-41. PubMed ID: 9759396
[TBL] [Abstract][Full Text] [Related]
17. Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.
Pejša V; Prka Ž; Lucijanić M; Mitrović Z; Piršić M; Jakšić O; Ajduković R; Kušec R
Croat Med J; 2017 Feb; 58(1):40-48. PubMed ID: 28252874
[TBL] [Abstract][Full Text] [Related]
18. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Vannata B; Laurenti L; Chiusolo P; Sorà F; Balducci M; Sabatelli M; Luigetti M; Giannotta C; De Stefano V; Leone G; Sica S
Am J Hematol; 2012 Jun; 87(6):641-2. PubMed ID: 22488443
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.
Kawajiri-Manako C; Sakaida E; Ohwada C; Miyamoto T; Azuma T; Taguchi J; Mori T; Hasegawa Y; Kondo T; Yujiri T; Yoshimitsu M; Imada K; Kurahashi S; Kahata K; Ichinohe T; Hirokawa M; Atsuta Y; Nakaseko C
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1180-1186. PubMed ID: 29409882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
